Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

  • There is currently no data for CRL

Director/PDMR Shareholding

9 Mar 2021 09:52

RNS Number : 6324R
Creightons PLC
09 March 2021
 

9 March 2021

 

 

 

Creightons PLC ("Creightons" or the "Company")

 

Director/PDMR Dealing

 

Issue of Equity

 

Total Voting Rights

 

Creightons plc announces that Paul Forster, a director of the Company, has advised that he disposed of 40,000 Ordinary Shares of 1p in the Company at an average price of 69.31p on 4 March 2021.

Following this transaction, the total combined beneficial holdings by Mr Forster and his wife, Mrs Forster, is now 1,143,318 ordinary 1p shares, 1.76% of the total issued share capital of the Company.

 

The Company also announces that, following the exercise of options over 95,000 shares by a member of staff under the block listing arrangement, the total number of shares in issue is now 64,852,243 and that this is the number of shares to be used as the denominator for calculating percentage shareholdings in the Company.

 

Market Abuse Regulation

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014 ("MAR").

 

Contacts

 

Nicholas O'Shea, Creightons plc 01733 281000

Roland Cornish /Felicity Geidt, Beaumont Cornish Limited 0207 628 3396

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail in respect of the Directors subscribing for Director Shares as described above.

 

 

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

Paul Forster

2

Reason for notification

a)

Position / status

Director

b)

Initial notification

/Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Creightons plc

b)

LEI

Not applicable

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1pence each in Creightons plc

 

ISIN GB0002341666

 

Nature of the transaction

Share disposal

 

Price(s) and volumes(s)

 

Price(s)

Volumes(s)

69.31

40,000

 

d)

Aggregated information

n/a

e)

Date of the transaction

4 March 2021

f)

Place of the transaction

London

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHJLMLTMTIMMMB
Date   Source Headline
23rd Apr 20263:05 pmRNSConfirmation of name change to Potter & Moore
23rd Apr 20267:01 amRNSChange of Name
23rd Apr 20267:00 amRNSTrading update for the year ended 31 March 2026
27th Mar 20264:35 pmRNSDirector / PDMR Shareholding
12th Mar 20265:42 pmRNSBlock Admission Six Monthly Return
5th Feb 202610:23 amRNSDirector/PDMR Shareholding
29th Jan 20269:31 amRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSInterim results for six months ended 30 Sept 2025
15th Sep 20257:00 amRNSBlock Listing and Total Voting Rights
29th Aug 20257:00 amRNSTotal Voting Rights
28th Aug 20253:22 pmRNSResults of Annual General Meeting
14th Aug 20257:00 amRNSExercise of Options, Director Dealing and TVR
30th Jul 20257:00 amRNSPosting of FY25 Annual Report and Notice of AGM
29th Jul 20251:28 pmRNSHoldings(s) in Company
23rd Jul 20252:11 pmRNSPDMR Dealing
16th Jul 20257:00 amRNSFY25 Audited Results and Notice of AGM
9th Jul 202510:30 amRNSNotice of Final Results and Investor Presentation
22nd May 20253:26 pmRNSDirector/PDMR Shareholding
6th May 20257:00 amRNSDirector/PDMR Shareholding
30th Apr 20257:00 amRNSPromotion of CFO to the Board of Directors
2nd Apr 20257:00 amRNSNotification of transactions by PDMR
1st Apr 20257:00 amRNSNotification of transactions by PDMR
31st Mar 20258:00 amRNSReadmission - Creightons Plc
31st Mar 20257:00 amRNSAdmission to AIM and first day of dealings
25th Mar 20253:23 pmRNSBoard Appointment
24th Mar 20256:00 pmRNSCreightons
20th Mar 202511:36 amRNSDirector/PDMR Shareholding
12th Mar 202512:43 pmRNSBlock listing Interim Review
3rd Mar 20257:33 amRNSResults of the General Meeting
28th Feb 20257:30 amRNSSchedule One - Creightons plc
6th Feb 20251:20 pmRNSProposed Delisting, Admission to AIM, Notice of GM
29th Jan 202512:59 pmRNSBoard Appointment
7th Jan 202511:46 amRNSHolding(s) in Company
10th Dec 20244:10 pmRNSDirectorate Change
28th Nov 20247:00 amRNSHalf-year Report
13th Nov 20247:00 amRNSUpdate on first half trading performance
28th Oct 20245:01 pmRNSNotification under UKLR 6.4.9(2)
25th Sep 20242:09 pmRNSDirector/PDMR Shareholding
20th Sep 202411:53 amRNSBlock listing Interim Review
18th Sep 20242:02 pmRNSTotal Voting Rights
4th Sep 20245:12 pmRNSDirector/PDMR Shareholding
29th Aug 20244:28 pmRNSResult of AGM
12th Aug 20242:14 pmRNSHolding(s) in Company
29th Jul 20243:45 pmRNSDividend Declaration
29th Jul 20241:52 pmRNSHolding(s) in Company
26th Jul 20242:59 pmRNSHolding(s) in Company
25th Jul 20245:30 pmRNSDirector/PDMR Shareholding
18th Jul 20247:00 amRNSPreliminary Results, Notice of AGM
8th Jul 20247:00 amRNSUpdate on Asset Impairment and Notice of Results
15th Mar 202410:52 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.